Hydroxyurea Dose Escalation Effective for Children with Sick

Extended follow-up of a phase 1/2 trial finds hydroxyurea dose optimization significantly improves clinical responses in children in sub-Saharan Africa with sickle cell.

Related Keywords

Banu Aygun , Linkedin Banu Aygun , Julie Kanter , Drug Administration , Birmingham School Of Medicine , Cohen Children Medical Center , University Of Alabama , Saharan Africa , Cohen Children , Birmingham School , Dose Escalation , Sickle Cell Anemia ,